Stockscreener 앱 받기
4.75
4.63%
0.21
시간 외 거래:
4.75
전일 마감가:
$4.54
열려 있는:
$4.55
하루 거래량:
157.37K
Relative Volume:
1.45
시가총액:
$236.87M
수익:
$15.33M
순이익/손실:
$-40.19M
주가수익비율:
-2.7109
EPS:
-1.7522
순현금흐름:
-
1주 성능:
+7.47%
1개월 성능:
+0.42%
6개월 성능:
-17.10%
1년 성능:
+5.79%
1일 변동 폭
$4.39
$4.75
1주일 범위
$4.19
$4.75
52주 변동 폭
$3.42
$5.88
Trisalus Life Sciences Inc Stock (TLSI) Company Profile
명칭
Trisalus Life Sciences Inc
전화
415 336 8917
주소
6272 WEST 91ST AVENUE, WESTMINSTER
TLSI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TLSI
Trisalus Life Sciences Inc
|
4.75 | 233.38M | 15.33M | -40.19M | 0 | -1.7522 |
|
ABT
Abbott Laboratories
|
127.63 | 231.95B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
97.78 | 142.60B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
369.25 | 141.45B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.04 | 123.83B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
72.65 | 43.07B | 5.69B | 1.41B | 577.90M | 6.9828 |
Trisalus Life Sciences Inc Stock (TLSI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-13 | 개시 | Lake Street | Buy |
| 2024-12-17 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-11-11 | 개시 | ROTH MKM | Buy |
| 2024-10-25 | 개시 | Northland Capital | Outperform |
| 2024-09-16 | 개시 | Oppenheimer | Outperform |
| 2024-05-30 | 개시 | Canaccord Genuity | Buy |
모두보기
Trisalus Life Sciences Inc 주식(TLSI)의 최신 뉴스
Regression analysis insights on TriSalus Life Sciences Inc. Equity Warrant performance2025 Top Decliners & Growth Focused Stock Reports - newser.com
What’s next for TriSalus Life Sciences Inc. stock priceDollar Strength & Free High Accuracy Swing Entry Alerts - newser.com
How TriSalus Life Sciences Inc. stock reacts to oil pricesJuly 2025 PostEarnings & AI Driven Stock Price Forecasts - newser.com
What high frequency data says about TriSalus Life Sciences Inc.July 2025 Rallies & Free Safe Entry Trade Signal Reports - newser.com
Can TriSalus Life Sciences Inc. stock surprise with earnings upsideEarnings Recap Summary & High Conviction Buy Zone Picks - newser.com
What high frequency data says about TriSalus Life Sciences Inc. Equity WarrantPortfolio Value Summary & Short-Term Swing Trade Alerts - newser.com
Tools to monitor TriSalus Life Sciences Inc. recovery probabilityJuly 2025 Analyst Calls & AI Based Buy and Sell Signals - newser.com
How resilient is TriSalus Life Sciences Inc. Equity Warrant stock in market downturnsEarnings Trend Report & Growth Focused Stock Reports - newser.com
Will breakout in TriSalus Life Sciences Inc. Equity Warrant lead to full recovery - newser.com
Published on: 2025-10-15 02:06:10 - newser.com
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Given Average Rating of “Buy” by Brokerages - Defense World
Statistical indicators supporting TriSalus Life Sciences Inc. Equity Warrant’s strength2025 Market Sentiment & Weekly High Return Opportunities - newser.com
Will TriSalus Life Sciences Inc. stock gain from strong economyWeekly Trend Summary & AI Driven Price Predictions - newser.com
TriSalus Life Sciences (NASDAQ:TLSIW) Trading 8.6% Higher – Still a Buy? - Defense World
Will TriSalus Life Sciences Inc. Equity Warrant stock recover after recent dropJuly 2025 Reactions & Consistent Return Strategy Ideas - newser.com
Published on: 2025-10-13 09:15:56 - newser.com
Custom strategy builders for tracking TriSalus Life Sciences Inc.Trade Analysis Report & Daily Volume Surge Signals - newser.com
Will TriSalus Life Sciences Inc. stock attract more institutional investorsWeekly Stock Summary & Accurate Buy Signal Alerts - newser.com
Automated trading signals detected on TriSalus Life Sciences Inc. Equity WarrantMarket Risk Analysis & Reliable Price Action Trade Plans - newser.com
Is it time to cut losses on TriSalus Life Sciences Inc.July 2025 PostEarnings & Real-Time Volume Analysis - newser.com
Published on: 2025-10-10 09:12:22 - newser.com
Will TriSalus Life Sciences Inc. stock deliver strong dividend growthJuly 2025 Weekly Recap & Daily Profit Focused Stock Screening - newser.com
Sentiment analysis tools applied to TriSalus Life Sciences Inc.Quarterly Portfolio Report & Growth Focused Entry Reports - newser.com
TriSalus Life Sciences' (TLSI) Sell (D-) Rating Reiterated at Weiss Ratings - MarketBeat
Published on: 2025-10-09 04:25:24 - newser.com
Volume spikes in TriSalus Life Sciences Inc. Equity Warrant stock – what they meanQuarterly Profit Review & AI Powered Market Entry Ideas - newser.com
Relative strength of TriSalus Life Sciences Inc. in sector analysisJobs Report & Short-Term Swing Trade Alerts - newser.com
Tick level data insight on TriSalus Life Sciences Inc. volatilityShare Buyback & Free Weekly Watchlist of Top Performers - newser.com
Quantitative breakdown of TriSalus Life Sciences Inc. recent moveMarket Weekly Review & Low Risk Growth Stock Ideas - newser.com
Will TriSalus Life Sciences Inc. outperform the marketWeekly Trend Report & Consistent Income Trade Ideas - newser.com
Using Bollinger Bands to evaluate TriSalus Life Sciences Inc. Equity Warrant2025 Historical Comparison & Accurate Intraday Trade Tips - newser.com
Is it too late to sell TriSalus Life Sciences Inc.July 2025 Update & Low Drawdown Trading Techniques - newser.com
How hedge fund analytics apply to TriSalus Life Sciences Inc. Equity Warrant stockJuly 2025 Fed Impact & Low Drawdown Investment Strategies - newser.com
How to build a custom watchlist for TriSalus Life Sciences Inc. Equity WarrantRecession Risk & Trade Opportunity Analysis - newser.com
Tools to monitor TriSalus Life Sciences Inc. Equity Warrant recovery probabilityTrade Analysis Summary & Safe Capital Allocation Plans - newser.com
Trisalus Life Sciences Inc (TLSI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Trisalus Life Sciences Inc 주식 (TLSI) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Devlin Jodi | Chief of Clinical Operations |
May 19 '25 |
Sale |
5.18 |
4,764 |
24,678 |
52,764 |
| Marshak Richard | Chief Commercial Officer |
May 19 '25 |
Sale |
5.18 |
6,597 |
34,172 |
69,101 |
| Stevens Jennifer | Chief Regulatory Officer |
May 19 '25 |
Sale |
5.18 |
8,704 |
45,087 |
77,640 |
| Young James Emmett | Chief Financial Officer |
Feb 05 '25 |
Buy |
5.65 |
6,000 |
33,900 |
30,000 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 30 '25 |
Buy |
5.28 |
5,010 |
26,453 |
444,259 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 29 '25 |
Buy |
5.03 |
5,030 |
25,301 |
439,249 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 27 '25 |
Buy |
5.42 |
4,826 |
26,157 |
429,503 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 28 '25 |
Buy |
5.12 |
4,716 |
24,146 |
434,219 |
| Murphy Sean | Chief Manuf, Strategy&Bus Dev. |
Jan 27 '25 |
Buy |
5.31 |
15,000 |
79,650 |
182,732 |
| Murphy Sean | Chief Manuf, Strategy&Bus Dev. |
Jan 28 '25 |
Buy |
5.17 |
15,000 |
77,550 |
197,732 |
1.23%
0.38%
자본화:
|
볼륨(24시간):